Gregory Russotti - 12 Jun 2026 Form 4 Insider Report for Century Therapeutics, Inc. (IPSC)

Reporting relationship: Title: Chief Technology and Manufacturing Officer
Issuer ticker: IPSC
Reported as of: 12 Jun 2026
Net transaction value: -$5,767
SEC form: 4
Accepted by SEC: 15 Jun 2026, 19:57:35 UTC
Prior SEC filing: 09 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Douglas Carr, Attorney-in-Fact

Key filing fact

Gregory Russotti filed Form 4 for Century Therapeutics, Inc. (IPSC) on 15 Jun 2026.

Key facts

This page summarizes Gregory Russotti's Form 4 filing for Century Therapeutics, Inc. (IPSC).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 15 Jun 2026, 19:57.

Change

Previous filing in this sequence was filed on 09 Jun 2026.
Current net transaction value: -$5,767.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001867305 Primary reporting owner

Russotti Gregory

Relationship: Title: Chief Technology and Manufacturing Officer
Address: C/O CENTURY THERAPEUTICS, INC., 25 N 38TH STREET, 12TH FLOOR, PHILADELPHIA
Signature: /s/ Douglas Carr, Attorney-in-Fact
Signature date: 15 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IPSC transaction

Common Stock

Sale

Transaction value: $5,767
Shares: -2,584
Change %: -0.5%
Price: $2.23
Shares after: 512,319
Date: 12 Jun 2026
Ownership: Direct
Footnotes: F1

IPSC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 92,773
Date: 12 Jun 2026
Ownership: By Gregory Russotti 2021 Family Trust

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person.

SEC remarks

Title: Chief Technology and Manufacturing Officer